β-淀粉样蛋白增加Wistar大鼠癫痫发作易感性的行为学研究

摘要
图/表
参考文献(20)
相关文章 (6)

全文: PDF (812 KB) HTML (1 KB)
输出: BibTeX | EndNote (RIS)

摘要目的研究β-淀粉样蛋白（Aβ）对癫痫（EP）发病机制的影响。方法按随机数字表法将40只6~8周Wistar大鼠分为Aβ1-42+PILO组、Aβ1-42组、PBS+PILO组、PBS组，每组各10只；前两组合称为Aβ1-42模型组，后两组合称为PBS对照组。采用脑立体定位仪在Aβ1-42模型组大鼠海马CA3区注入Aβ1-42，PBS对照组给予相同剂量的PBS。2周后观察大鼠Morris水迷宫实验，记录逃避潜伏期、目标象限内游泳时间比例和穿越平台次数，检测大鼠AD模型是否成功。建模成功后通过腹腔（IP）注射氯化锂-匹罗卡品（LI-PILO）制备大鼠慢性EP模型，依据Racine分级标准，记录EP发作潜伏期、发作程度和死亡率。结果 Aβ1-42模型组和PBS对照组各有1只大鼠死亡。Morris水迷宫实验数据分析结果，Aβ1-42 模型组与PBS对照组大鼠相比，逃避潜伏期显著延长（P < 0.01），目标象限内游泳时间比例缩短（P < 0.05），穿越平台次数显著减少（P < 0.05），表明AD模型制备成功。制备大鼠EP模型：依据Racine分级标准，Aβ1-42+PILO组与PBS+PILO组相比，EP发作潜伏期显著缩短（P < 0.01），发作程度更重（P < 0.05）；Aβ1-42+PILO组与PBS+PILO组相比死亡率显著增加（P < 0.05）。结论通过海马CA3区注射Aβ1-42，可以导致大鼠出现与海马有关的学习和记忆功能受损。在Aβ存在的基础上诱导大鼠出现EP发作的易感性增加。

	服务

	把本文推荐给朋友
	加入我的书架
	加入引用管理器
	E-mail Alert
	RSS
	作者相关文章
	赵娟1 张彦妹2 郑乃智1

关键词 ： &beta, -淀粉样蛋白, 癫痫, 阿尔茨海默病, 易感性

Abstract：Objective To study the effects of β-amyloid protein (Aβ) on the pathogenesis of epilepsy (EP). Methods 40 male Wistar rats were divided into Aβ1-42 + PILO group, Aβ1-42 group, PBS + PILO group and PBS group by random number table, with 10 rats in each group. The former two groups were called Aβ1-42 model group and the later PBS control group. Aβ1-42 and same volume PBS were injected into the hippocampal CA3 region of Wistar rats in Aβ1-42 model group and PBS control group by stereotaxic apparatus respectively, and the Morris water maze test was observed after 2 weeks. Escape latency, the percentage of swimming time in the target quadrant and the number of times of crossing the platform were recorded. After the AD model was successfully made, the rat model of chronic EP was established by intraperitoneal injection of LI-PILO. The latency of EP, degree of seizure and mortality of rats were recorded according to Racine grading criteria. Results One rat died in Aβ1-42 model group and the PBS control group. The results of Morris water maze test showed that compared with the PBS control group, the escape latency of the Aβ1-42 model group was longer (P < 0.01), the proportion of swimming time in the target quadrant was shorter (P < 0.05), and the number of crossing the platform was also significantly reduced (P < 0.05). It indicated that the AD model was successfully prepared. Preparation of rats EP model: The latency of EP in Aβ1-42 + PILO group was significantly shorter (P < 0.01), and the degree of seizure was more severe (P < 0.05), compared with PBS + PILO group, according to Racine grading criteria. The mortality of rats in Aβ1-42 + PILO group was significantly increased compared with PBS + PILO group (P < 0.05). Conclusion It can lead to the impaired hippocampus-related learning and memory function by injection of Aβ1-42 in hippocampal CA3 region of rats. The existing of Aβ increasing the susceptibility to EP in the rats, which indicates that Aβ plays a facilitation role in the occurrence of EP.

Key words： Beta amyloid protein Epilepsy Alzheimer disease Susceptibility

基金资助:山东省青岛市科技局项目（KJZD-13-13-NSH）。

通讯作者: 郑乃智（1963-），男，博士，教授，硕士生导师，主要从事各种癫痫的诊断及治疗。

作者简介: 赵娟（1990-），女，青岛大学2014级神经病学专业在读硕士研究生；研究方向：癫痫发病机制及治疗。

引用本文:

赵娟1 张彦妹2 郑乃智1. β-淀粉样蛋白增加Wistar大鼠癫痫发作易感性的行为学研究[J]. 中国医药导报, 2017, 14(27): 25-28,36.
ZHAO Juan1 ZHANG Yanmei2 ZHENG Naizhi1 . The behavior study on the increase of susceptibility to epilepsy in Wistar rats by β-amyloid protein. 中国医药导报, 2017, 14(27): 25-28,36.

链接本文:

http://www.yiyaodaobao.com.cn/CN/ 或 http://www.yiyaodaobao.com.cn/CN/Y2017/V14/I27/25

[1] Brooks-Kayal AR，Bath KG，Berg AT，et al. Issues related to symptomatic and diseaase-modifying treatments affecting cognitive and neuropsychiatric comorbidities of epilepsy [J]. Epilepsia，2013，54（4）：44-60.
[2] Bae EK，Jung KH，Chu K，et al. Neuropathologic and clinical features of human medial temporal lobe epilepsy [J]. J Clin Neurol，2010，6（2）：73-80.
[3] Sillanpaa M，Gissler M，Schmidt D. Efforts in epilepsy prevention in the last 40 years：lessons from a large nation wide study [J]. JAMA Neurol，2016，73（4）：390-395.
[4] Quan Q，Wang J，Li X，et al. Ginsenoside Rg1 decreases Abeta（1-42）level by upregulating PPARγ and IDE expression in the hippocampus of a rat model of Alzheimer′s disease [J]. PLoS One，2013，8（3）：e591-595.
[5] Jia S，Lu Z，Gao Z，et al. Chitosan oligosaccharides alleviate cognitive deficits in an amyloid-beta1-42-induced rat model of Alzheimer′s disease [J]. Int J Biol Macromol，2016， 83：416-425.
[6] Fang Z， Chen S，Qin J，et al. Pluronic P85- coated poly（butylcyanoacrylate）nanoparticles overcome phenytoinresistance in P-glycoprotein overexpressing rats with lithium- pilocarpine-inducedchronic temporal lobe epilepsy [J]. Biomaterials，2016，97：110-121.
[7] Racine RJ. Modification of seizure activity by electrical stimulation.Ⅱ. Motor seizure，Electroencephalogr [J]. Electroencephalogr Clin Neurophysiol，1972，32（3）：281-294.
[8] Tuchman R，Alessandri M，Cuccaro M. Autism spectrum disorders and epilepsy：moving towards a comprehensive approach to treatment [J]. Brain Dev，2010，32（9）：719-730.
[9] Jonsson T，Atwal JK，Steinberg S，et al. A mutation in APP protects against Alzheimer disease and age-related cognitive deline [J]. Nature，2012，488（7409）：96-99.
[10] Enache TA，Oliveira-Brett AM. Alzheimer′s disease amyloid beta peptides in vitro electrochemical oxidation [J]. Bioelectrochemistry，2016，114：13-23.
[11] Lahmy V，Meunier J，Malmstrom S，et al. Blockade of Tau hyperphosphorylation and Aβ1-42 generation by the aminotetrahydrofuran derivative ANAVEX2-73，a mixed muscarinic and σ1 receptor agonist，in a nontransgenic mouse model of Alzheimer′s disease [J]. Neuropsychopharmacology，2013，38（9）：1706-1723.
[12] 刘阳，韩春雷，孟凡刚.匹罗卡品癫痫模型研究进展[J].中华神经外科杂志，2014，30（1）：88-90.
[13] Born HA，Kim JY，Savjani RR，et al. Genetic suppression of transgenic APP rescues hypersynchronous network activity in a mouse model of Alzeimer′s disease [J]. J Neurosci，2014，34（11）：3826-3840.
[14] Roberson ED，Halabisky B，Yoo JW，et al. Amyloid-beta/Fyn-induced synaptic，network，and cognitive impairments depend on tau levels in multiple mouse models of Alzheimer's disease [J]. J Neurosci，2011，31（2）：700-711.
[15] Chandra V，Bharucha NE，Schoenberg BS. Conditions associated with Alzheimer disease at death：case–control study [J]. Neurology，1986，36（2）：209–211.
[16] Corcoran KA，Lu Y，Turner RS，et al. Over expression of hAPPswe impairs rewarded alternation and contextual fear conditioning in a transgenic mouse model of Alzheimer disease [J]. Learn Mem，2002，9（5）：243–252.
[17] Palop JJ，Mucke L. Network abnormalities and interneuron dysfunction in Alzheimer disease [J]. Nat Rev Neurosci.2016，17（12）：777-792.
[18] Palop JJ，Chin J，Roberson ED，et al. Aberrant excitatory neuronal activity and compensatory remodeling of inhibitory hippocampal circuits in mouse models of Alzheimer′s disease [J]. Neuron，2007，55（5）：697-711.
[19] Scarmeas N，Honig LS，Choi H. Seizure in Alzheimer disease：who，when，and how common？[J] Arch Network，2009，66（8）：435-440.
[20] Luscher C，Malenka RC. Drug-evoked synaptic plasticity in addiction：from molecular changes to circuit remodeling [J]. Neuron，2011，69（4）：650-663.